Berkshire Hathaway In Discussions with Graham Holdings Co (GHC) Regarding a Split-off Transaction

Warren Buffett and Berkshire and Graham Holdings Co (NYSE:GHC) are discussing to acquire an unformed subsidiary of  Graham, according to a filing with the Securities and Exchange Commission. This potential subsidiary would own some assets and a business of Graham and might include shares of Berkshire common stock owned by Graham Holdings Co (NYSE:GHC) in exchange for all the class B common stock held by Berkshire.

If the deal is signed Berkshire would turn over its Graham stake and if the transaction does not succeed, then Berkshire might acquire additional shares of Class B Stock, or dispose the securities, which would depend on the performance of its performance in the market

Berkshire Hathaway also disclosed that it owns 1.73 million shares of Graham Holdings Co (NYSE:GHC). The current stake amasses 27.8% of the company’s class B common stock.

Berkshire Hathaway

Washington Post Co. changed its name to Graham Holdings Co (NYSE:GHC) after selling its flagship newspaper to, Inc. (NASDAQ:AMZN). Graham Holdings is a diversified education and media company.

Earlier, Graham Holdings Co (NYSE:GHC) approved an increase in the annual dividend from $9.80 to $10.20 per share. The company paid $2.55 per share of dividend for the first quarter of 2014.

Last month, Berkshire Hathaway boosted its stake in USG Corporation (NYSE:USG) to 43.4 million shares from around 17.1 million held earlier. The stake is activist in nature amassing 30.5% of the company’s common stock.

A couple of months ago, Warren Buffett that it upped its stake in DaVita HealthCare Partners Inc (NYSE:DVA) to 36.5 million shares by purchasing 1.3 million shares of the company.

Warren Buffett, had 20.79% of its equity portfolio invested in Wells Fargo & Co (NYSE:WFC), of which it held 463.13 million shares at the end of the third quarter of 2013.

Disclosure: none

Recommended reading:

Adage Capital Management Reiterates Stake in CARDIOME PHARMA CORP (CRME)

Insider at Integrated Device Technology (IDTI) Makes A Million-Dollar Purchase Before Stock Price Continues to Escalate

Hedge Fund News: Whitney Tilson, Daniel Loeb & Ray Dalio

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!